These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29334132)

  • 21. Survival study of treatment adherence by patients given oral oxibutynin for hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; García-Montero P; García-Harana C; Rivas Ruiz F; de Troya-Martín M
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1034-1037. PubMed ID: 29220103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin.
    Teivelis MP; Wolosker N; Krutman M; Kauffman P; Campos JR; Puech-Leão P
    Clinics (Sao Paulo); 2014 Sep; 69(9):608-14. PubMed ID: 25318092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial study of transdermal oxybutynin for treating hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; Toledo-Pastrana T; Nieto-Guindo M; García-Montero P; de Troya-Martín M
    J Dermatol; 2017 Jun; 44(6):717-720. PubMed ID: 28106275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary hyperhidrosis controlled with oxybutynin after unsuccessful surgical treatment.
    Wozniacki L; Zubilewicz T
    Clin Exp Dermatol; 2009 Dec; 34(8):e990-1. PubMed ID: 20055880
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxybutynin gel versus nanoemulgel for treating primary palmar hyperhidrosis: A pilot double-blind randomized controlled trial.
    Saki N; Shakouri N; Rastaghi F; Hosseini SA; Alipour S; Ahramiyanpour N
    J Cosmet Dermatol; 2023 Aug; 22(8):2268-2272. PubMed ID: 36999480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study.
    Campanati A; Gregoriou S; Consales V; Rizzetto G; Bobyr I; Diotallevi F; Martina E; Kontochristopoulos G; Platsidaki E; Offidani A
    Dermatol Ther; 2020 Nov; 33(6):e14039. PubMed ID: 32691938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders.
    Wolosker N; Krutman M; Campdell TP; Kauffman P; Campos JR; Puech-Leão P
    Einstein (Sao Paulo); 2012; 10(4):405-8. PubMed ID: 23386077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life before hyperhidrosis treatment as a predictive factor for oxybutynin treatment outcomes in palmar and axillary hyperhidrosis.
    Wolosker N; Krutman M; Teivelis MP; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
    Ann Vasc Surg; 2014 May; 28(4):970-6. PubMed ID: 24333527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term evaluation of the safety and efficacy of a novel 20% oxybutynin hydrochloride lotion for primary palmar hyperhidrosis: An open-label extension study.
    Fujimoto T; Terahara T; Okawa K; Inakura H; Hirayama Y; Yokozeki H
    J Dermatol; 2023 Nov; 50(11):1459-1472. PubMed ID: 37605375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-life experience with oral oxybutynin long-term continuous therapy in severe hyperhidrosis and systematic review of the literature.
    Briatico G; Pampena R; Fulgione E; Babino G; Giorgio CM; D'Ambra I; Caccavale S; Longo C; Argenziano G
    Dermatol Ther; 2021 Mar; 34(2):e14832. PubMed ID: 33527699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An alternative to treat palmar hyperhidrosis: use of oxybutynin.
    Wolosker N; de Campos JR; Kauffman P; Neves S; Yazbek G; Jatene FB; Puech-Leão P
    Clin Auton Res; 2011 Dec; 21(6):389-93. PubMed ID: 21688168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
    Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA
    Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; Kauffman P; de Campos JR; Puech-Leão P
    Ann Vasc Surg; 2014 Jul; 28(5):1106-12. PubMed ID: 24512855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled study.
    Kay GG; Staskin DR; MacDiarmid S; McIlwain M; Dahl NV
    Clin Drug Investig; 2012 Oct; 32(10):707-14. PubMed ID: 22909146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
    Enzelsberger H; Kurz C; Helmer H; Mittermayer F
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of oxybutynin for treatment of hyperhidrosis in overweight and obese patients.
    Wolosker N; Krutman M; Kauffman P; Paula RP; Campos JR; Puech-Leão P
    Rev Assoc Med Bras (1992); 2013; 59(2):143-7. PubMed ID: 23582555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Efficacy of Oxybutynin for Palmar and Plantar Hyperhidrosis in Children Younger than 14 Years.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; Schvartsman C; Kauffman P; de Campos JR; Puech-Leão P
    Pediatr Dermatol; 2015; 32(5):663-7. PubMed ID: 25490865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of oxybutynin for treating facial hyperhidrosis.
    Wolosker N; Campos JR; Kauffman P; Munia MA; Neves S; Jatene FB; Puech-Leão P
    An Bras Dermatol; 2011; 86(3):451-6. PubMed ID: 21738960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of oxybutynin for treating plantar hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Yazbek G; Neves S; Puech-Leao P
    Int J Dermatol; 2013 May; 52(5):620-3. PubMed ID: 23590378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical Oxybutynin 3% Gel Versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis.
    El-Agamy El-Samadony A; Hegab DS; El Maghraby GM; El-Maadawy IH
    Dermatol Pract Concept; 2023 Jul; 13(3):. PubMed ID: 37557105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.